Novel tumor marker REG4 detected in serum of patients with resectable pancreatic cancer and feasibility for antibody therapy targeting REG4. (Q34558669)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Novel tumor marker REG4 detected in serum of patients with resectable pancreatic cancer and feasibility for antibody therapy targeting REG4.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Novel tumor marker REG4 detected in serum of patients with resectable pancreatic cancer and feasibility for antibody therapy targeting REG4. (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1 reference

based on heuristic

inferred from title

pancreatic cancer

1 reference

based on heuristic

inferred from title

Hidetoshi Eguchi

2

object named as

Hidetoshi Eguchi

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Hidewaki Nakagawa

9

object named as

Hidewaki Nakagawa

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

author name string

Akio Takehara

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Hiroaki Ohigashi

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Osamu Ishikawa

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Tsutomu Kasugai

5

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Masayo Hosokawa

6

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Toyomasa Katagiri

7

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Yusuke Nakamura

8

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

publication date

17 August 2006

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

97

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1191-1197

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. American Gastroenterological Association

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00297.X

21 January 2018

Surgery for pancreatic cancer: recent controversies and current practice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00297.X

21 January 2018

Serum tumor markers and molecular biological diagnosis in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00297.X

21 January 2018

Evaluation of a serologic marker, CA19-9, in the diagnosis of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00297.X

21 January 2018

Genome-wide cDNA microarray analysis of gene expression profiles in pancreatic cancers using populations of tumor cells and normal ductal epithelial cells selected for purity by laser microdissection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00297.X

21 January 2018

Isolation and characterization of a cDNA encoding a novel member of the human regenerating protein family: Reg IV.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00297.X

21 January 2018

REG Ialpha protein may function as a trophic and/or anti-apoptotic factor in the development of gastric cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00297.X

21 January 2018

Reg IV activates the epidermal growth factor receptor/Akt/AP-1 signaling pathway in colon adenocarcinomas

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00297.X

21 January 2018

Reg IV, a new member of the regenerating gene family, is overexpressed in colorectal carcinomas

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00297.X

21 January 2018

Gene expression profile of gastric carcinoma: identification of genes and tags potentially involved in invasion, metastasis, and carcinogenesis by serial analysis of gene expression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00297.X

21 January 2018

Reg IV: a promising marker of hormone refractory metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00297.X

21 January 2018

RELP, a novel human REG-like protein with up-regulated expression in inflammatory and metaplastic gastrointestinal mucosa

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00297.X

21 January 2018

Developments in the systemic therapy of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00297.X

21 January 2018

Reg gene family and human diseases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00297.X

21 January 2018

Fully human monoclonal antibodies to hepatocyte growth factor with therapeutic potential against hepatocyte growth factor/c-Met-dependent human tumors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00297.X

21 January 2018

Identifiers

10.1111/J.1349-7006.2006.00297.X

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34558669&oldid=2107010464"